This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AngioDynamics' CEO Discusses Q3 2012 Results - Earnings Call Transcript

AngioDynamics (ANGO)

Q3 2012 Earnings Call

April 04, 2012 4:30 pm ET

Executives

Bob Jones -

Joseph M. DeVivo - Chief Executive Officer, President and Director

D. Joseph Gersuk - Chief Financial Officer, Chief Accounting Officer, Executive Vice President and Treasurer

Analysts

Matthew Hewitt - Craig-Hallum Capital Group LLC, Research Division

Jamar Ismail - Canaccord Genuity, Research Division

Jayson T. Bedford - Raymond James & Associates, Inc., Research Division

Charles Croson - Sidoti & Company, LLC

Robert M. Goldman - CL King & Associates, Inc.

Larry Haimovitch - Haimovitch Medical Technology Consultants

Presentation

Operator

Good day, ladies and gentlemen. Thank you for standing by. Welcome to the AngioDynamics Third Quarter Fiscal 2012 Financial Earnings Conference Call. [Operator Instructions] This conference is being recorded today, Wednesday, April 4, 2012. I would now like to turn the conference over to Mr. Bob Jones of EVC Group. Please go ahead.

Bob Jones

Thank you, Alicia, and thank you everyone for joining us today for the AngioDynamics conference call to review the results of the fiscal 2012 third quarter, which ended on February 29, 2012.

The news release announcing the results crossed the wire this afternoon after the market close and are available on the AngioDynamics website. The call is being broadcast live on the web at www.angiodynamics.com.

A replay of the call will be also archived on the AngioDynamics website. To access both the website and the archived replay, go to the Investors section under Events and Presentations.

Before we get started, during the course of this conference call, the company will make projections and forward-looking statements regarding future events, including statements about revenue and earnings for fiscal 2012.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs